A phase IB/IL study of gemcitabine and docetaxel in combination with pazopanib for the neoadjuvant treatment of soft tissue sarcomas Academic Article uri icon

Overview

MeSH Major

  • Deoxycytidine
  • Pyrimidines
  • Sarcoma
  • Sulfonamides
  • Taxoids

abstract

  • GDP combination used in the neoadjuvant setting resulted in significant toxicity; despite pathologic responses, no objective responses occurred.

publication date

  • October 8, 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4718433

Digital Object Identifier (DOI)

  • 10.1634/theoncologist.2015-0245

PubMed ID

  • 26449382

Additional Document Info

start page

  • 1245

end page

  • 6

volume

  • 20

number

  • 11